Total Payments
$327,895
2024 Payments
$21,505
Companies
44
Transactions
1,845
Medicare Patients
4,451
Medicare Billing
$490,985
Payment Breakdown by Category
Other$250,586 (76.4%)
Travel$42,535 (13.0%)
Food & Beverage$32,317 (9.9%)
Consulting$2,430 (0.7%)
Education$18.11 (0.0%)
Gifts$10.06 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $213,161 | 123 | 65.0% |
| Travel and Lodging | $42,535 | 117 | 13.0% |
| Food and Beverage | $32,317 | 1,571 | 9.9% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $20,800 | 7 | 6.3% |
| Compensation for serving as faculty or as a speaker for a medical education program | $16,625 | 7 | 5.1% |
| Consulting Fee | $2,430 | 2 | 0.7% |
| Education | $18.11 | 17 | 0.0% |
| Gift | $10.06 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $165,563 | 550 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $51,233 | 406 | $0 (2024) |
| Synergy Pharmaceuticals Inc | $34,855 | 54 | $0 (2018) |
| Allergan, Inc. | $30,822 | 97 | $0 (2020) |
| Takeda Pharmaceuticals U.S.A., Inc. | $12,748 | 100 | $0 (2024) |
| UCB, Inc. | $10,132 | 40 | $0 (2020) |
| Valeant Pharmaceuticals North America LLC | $4,825 | 38 | $0 (2017) |
| PFIZER INC. | $3,650 | 92 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $3,220 | 44 | $0 (2024) |
| Ardelyx, Inc. | $1,832 | 40 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $21,505 | 271 | ABBVIE INC. ($18,189) |
| 2023 | $30,077 | 268 | ABBVIE INC. ($14,898) |
| 2022 | $51,369 | 310 | ABBVIE INC. ($37,719) |
| 2021 | $29,562 | 214 | AbbVie Inc. ($15,055) |
| 2020 | $16,187 | 127 | AbbVie Inc. ($12,022) |
| 2019 | $68,250 | 239 | AbbVie, Inc. ($26,114) |
| 2018 | $55,274 | 217 | AbbVie, Inc. ($18,787) |
| 2017 | $55,671 | 199 | AbbVie, Inc. ($22,779) |
All Payment Transactions
1,845 individual payment records from CMS Open Payments — Page 1 of 74
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $29.72 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: Gastroenterology | ||||||
| 12/20/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $26.88 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $8.18 | General |
| Category: Gastroenterology | ||||||
| 12/17/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug), Linzess | Food and Beverage | Cash or cash equivalent | $14.26 | General |
| Category: GI | ||||||
| 12/16/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $8.33 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/13/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $23.99 | General |
| Category: Oncology | ||||||
| 12/13/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $9.50 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,325.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $95.55 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: Immunology | ||||||
| 12/04/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $22.84 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: Gastroenterology | ||||||
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $9.09 | General |
| Category: Gastroenterology | ||||||
| 12/02/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $28.86 | General |
| Category: Immunology | ||||||
| 12/02/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/02/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $7.48 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/02/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $1.94 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $8.14 | General |
| Category: Gastroenterology | ||||||
| 11/26/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $10.17 | General |
| Category: IMMUNOLOGY | ||||||
| 11/25/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $11.29 | General |
| Category: Gastroenterology | ||||||
| 11/21/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $22.09 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 11/20/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/15/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $4.50 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,014 | 1,122 | $770,325 | $107,950 |
| 2022 | 12 | 1,062 | 1,176 | $766,165 | $110,661 |
| 2021 | 13 | 1,169 | 1,358 | $938,215 | $142,779 |
| 2020 | 16 | 1,206 | 1,425 | $872,708 | $129,596 |
Total Patients
4,451
Total Services
5,081
Medicare Billing
$490,985
Procedure Codes
55
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 270 | 312 | $43,680 | $20,085 | 46.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 187 | 228 | $45,600 | $19,657 | 43.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 64 | 64 | $124,480 | $12,962 | 10.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 86 | 87 | $160,515 | $9,318 | 5.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 118 | 121 | $158,510 | $8,346 | 5.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 57 | 57 | $14,535 | $7,283 | 50.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 52 | 54 | $14,850 | $7,251 | 48.8% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 41 | 41 | $72,160 | $6,191 | 8.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 38 | 57 | $8,550 | $5,454 | 63.8% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 29 | 29 | $51,040 | $5,331 | 10.4% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 17 | 17 | $29,920 | $3,130 | 10.5% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 20 | 20 | $27,000 | $1,757 | 6.5% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 13 | 13 | $16,185 | $1,087 | 6.7% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2023 | 22 | 22 | $3,300 | $97.25 | 2.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 302 | 373 | $52,220 | $24,305 | 46.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 160 | 186 | $37,200 | $16,668 | 44.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 74 | 74 | $143,930 | $14,585 | 10.1% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 73 | 73 | $128,480 | $10,891 | 8.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 128 | 133 | $174,230 | $9,532 | 5.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 83 | 83 | $153,135 | $9,106 | 5.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 54 | 55 | $15,125 | $8,649 | 57.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 61 | 61 | $15,555 | $7,683 | 49.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 52 | 59 | $8,850 | $4,907 | 55.5% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2022 | 20 | 21 | $28,350 | $2,450 | 8.6% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 23 | 26 | $4,290 | $1,767 | 41.2% |
About Dr. Morris Elevado, M.D
Dr. Morris Elevado, M.D is a Gastroenterology healthcare provider based in Cranston, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/08/2005. The National Provider Identifier (NPI) number assigned to this provider is 1417941105.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Morris Elevado, M.D has received a total of $327,895 in payments from pharmaceutical and medical device companies, with $21,505 received in 2024. These payments were reported across 1,845 transactions from 44 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($213,161).
As a Medicare-enrolled provider, Elevado has provided services to 4,451 Medicare beneficiaries, totaling 5,081 services with total Medicare billing of $490,985. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Cranston, RI
- Active Since 09/08/2005
- Last Updated 10/15/2025
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1417941105
Products in Payments
- Trulance (Drug) $34,855
- SKYRIZI (Biological) $34,656
- TRULANCE (Drug) $31,018
- LINZESS (Drug) $28,751
- Creon (Drug) $26,995
- CREON (Drug) $24,287
- XIFAXAN (Drug) $20,298
- RINVOQ (Biological) $17,817
- Humira (Biological) $13,558
- HUMIRA (Biological) $12,974
- MOTEGRITY (Drug) $10,930
- Cimzia (Drug) $10,132
- VIBERZI (Drug) $6,727
- UCERIS (Drug) $4,571
- Linzess (Drug) $2,840
- COLOGUARD (Device) $2,525
- IBSRELA (Drug) $1,832
- CIMZIA (Drug) $1,673
- ENTYVIO (Biological) $1,155
- XELJANZ (Drug) $1,083
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Cranston
Colin Woodard, Do, DO
Gastroenterology — Payments: $8,820
Gastroenterology $8,820
Thomas Mcgreen, M.d, M.D
Gastroenterology — Payments: $7,672
Gastroenterology $7,672
Robert Wolfgang, D.o, D.O
Gastroenterology — Payments: $6,692
Gastroenterology $6,692
George Powers, M.d, M.D
Gastroenterology — Payments: $1,319
Gastroenterology $1,319
Paul Roderick, M.d, M.D
Gastroenterology — Payments: $1,317
Gastroenterology $1,317
Philip Opalenski, Md, MD
Gastroenterology — Payments: $568.20
Gastroenterology $568.20